找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Immunoconjugate Therapy of Hematologic Malignancies; Steven T. Rosen,Timothy M. Kuzel Book 1993 Springer Science+Business Media New York 1

[復(fù)制鏈接]
樓主: 五個
31#
發(fā)表于 2025-3-26 23:14:48 | 只看該作者
32#
發(fā)表于 2025-3-27 03:40:14 | 只看該作者
33#
發(fā)表于 2025-3-27 05:46:20 | 只看該作者
n hydrodynamics will require four assumptions in addition to the assumption that a small element of the fluid obeys Newton’s second law. Except for Sects. 4.5 and 4.6 this chapter will be concerned with the simplest cases, in which the . particles can be considered one at a time, each one obeying Ne
34#
發(fā)表于 2025-3-27 09:49:56 | 只看該作者
35#
發(fā)表于 2025-3-27 17:41:54 | 只看該作者
New approaches to radiolabeling monoclonal antibodies,njected dose per gram, localizes in tumor following intravenous injection [.]. The low tumor uptake in patients may be related to such factors as antibody dilution following injection [.], the slow rate of diffusion or penetration of antibody molecules across the vascular endothelium [.], and restricted blood flow in tumor tissue [.].
36#
發(fā)表于 2025-3-27 21:06:19 | 只看該作者
Immunotoxins for the therapy of graft versus host disease,ransplant therapy to those without such a donor through the use of bone marrow from mismatched related or matched unrelated donors. Once moderate to severe GVHD occurs, up to half of patients will die despite therapeutic intervention.
37#
發(fā)表于 2025-3-27 22:22:18 | 只看該作者
Radioimmunotherapy of lymphoma,, mention new obstacles to successful incorporation of radiolabeled MoAbs into standard oncologic therapy, and suggest future directions that may lead to enhanced effectiveness of radioimmunoconjugates.
38#
發(fā)表于 2025-3-28 04:14:35 | 只看該作者
Imaging and dosimetry determinations using radiolabeled antibodies, technology [.], the development of radiolabeled anti-tumor monoclonal antibodies (MoAb) as imaging and therapeutic reagents promises to add an element of specificity not previously available with conventional techniques.
39#
發(fā)表于 2025-3-28 08:15:59 | 只看該作者
40#
發(fā)表于 2025-3-28 12:30:40 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-26 12:56
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
岳西县| 大城县| 华亭县| 凉城县| 富锦市| 宁阳县| 腾冲县| 新巴尔虎右旗| 关岭| 舟曲县| 乐东| 恩施市| 会昌县| 公主岭市| 克东县| 拉孜县| 山东省| 应用必备| 嵊州市| 和田县| 炎陵县| 手机| 饶河县| 城固县| 安溪县| 德阳市| 绥芬河市| 册亨县| 尚义县| 南乐县| 阜新| 绥棱县| 抚顺县| 罗田县| 会泽县| 乌兰县| 唐山市| 临江市| 长泰县| 集贤县| 突泉县|